The pandemic hasn't helped or hurt Medicare's solvency
Axios #5 - 9 months ago

Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal
New York Times #11 - 6 weeks ago

Dr Oz Wants to Privatize Medicare
Jacobin #1 - 20 hours ago

VA Health System Won’t Cover Biogen’s Alzheimer’s Drug
Wall Street Journal #22 - 4 weeks ago

Medicare pays millions for remote vital sign monitoring. Is it worth it?
Washington Post #17 - 15 months ago

Feds killed plan to curb medicare advantage overbilling after industry opposition
CBS #17 - 2 weeks ago

He and his wife both got cataract surgery. His bill was 20 times higher than hers
NPR Online News #5 - 4 weeks ago

Medicare Advantage or Just Medicare?
New York Times #36 - 2 months ago

FDA gives an early nod to psychedelic research
Washington Post #37 - 8 months ago

Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
CNBC #10 - 4 years ago

Even Dr. Oz Can’t Break Medicare
Mother Jones #1 - 3 months ago

Dr Oz to face Senate grilling on Capitol Hill in bid to run Centers for Medicare and Medicaid
FOX News #18 - 4 weeks ago

Medicare announces plan to recoup billions from drug companies
NPR Online News #14 - 4 weeks ago

Biden's families plan excludes Medicare expansion, drug price changes backed by Democrats
CNBC #9 - 4 years ago

Medicare Advantage auditing rule stuck in limbo
Axios #5 - 4 weeks ago

Sen. Braun demands full audit of Medicare after massive fraud discovery
FOX News #16 - 13 months ago

Democrats Say Paid Family and Medical Leave Back in Domestic Policy Bill
Time #7 - 3 months ago

UnitedHealth Responds to DOJ Investigation Reports: 'Deeply Irresponsible'
Newsweek #4 - 4 weeks ago

RSV Vaccines Aren’t Covered By Medicare For These Vulnerable Groups
Forbes #4 - 2 months ago

Why drug price negotiation has staying power
Axios #6 - 6 weeks ago

Nearly $50,000 a week for a cancer drug? A man worries about bankrupting his family
NPR Online News #6 - 3 weeks ago

Medicare Penalties Would Change for 700,000 Seniors Under New Bill
Newsweek #31 - 9 days ago

Medicare Won’t Pay For Controversial Alzheimer’s Drug Aduhelm Without A New Trial
Forbes #4 - 4 years ago

Weight-loss drugs are so popular they’re headed for Medicare negotiations
Washington Post #17 - 8 months ago

Joe Biden Is Privatizing Medicare
Jacobin #1 - 20 hours ago

Medicare Drug-Pricing Debate Pits Savings Against Innovation
Wall Street Journal - 4 weeks ago

Here's how one drug can be responsible for 50% of the hike in Medicare's Part B premiums
CNBC #10 - 11 years ago

Americans aren’t giving Biden much credit for his popular Medicare drug price negotiations, AP-NORC poll says
PBS NewsHour #10 - 3 weeks ago

Joe Biden Is Quietly Pursuing the Creeping Privatization of Medicare
Jacobin #1 - 20 hours ago

Despite Trump’s Accusations, Democrats Have Largely Avoided Medicare for All
New York Times #6 - 2 months ago

How Did We End Up with Such an Opaque and Costly Health-Care System?
New Yorker #2 - 5 days ago

WATCH LIVE: Pelosi offers briefing amid Biden transition
PBS NewsHour #15 - 8 months ago

House Democrats push Biden to lower Medicare eligibility age
CBS #4 - 3 months ago

Democrats Propose Raising Taxes on Some High Earners to Bolster Medicare
New York Times #13 - 6 months ago

Multibillion-dollar healthcare fraud scheme included giving people 'unnecessary' skin grafts: DOJ
FOX News #28 - 2 weeks ago

US charges 11 people in Russia-based scheme to bilk Medicare of $10bn
Guardian #13 - 4 weeks ago

Legal fights and loopholes could blunt Medicare's new power to control drug prices
NPR Online News #11 - 4 months ago

Congress members send letter to HCA about conditions at Florida hospital after NBC News report
NBC #12 - 13 months ago

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Associated Press #11 - 3 months ago

Donald Trump Issues Update on Social Security, Medicaid
Newsweek #3 - 2 months ago
More Medicare News


Political Stance
Split
Left
Right
Establishment Stance
Split
Critical
Pro
Writing Style
Provocative
Nuanced
Depth
Breezy
Detailed
Shelf-Life
Short
Long
Recency
Evergreen
Latest